Recently, a study showed that the high expression of IL-1β in the intestinal mucosa was associated with resistance to corticosteroid therapy and treatment with TNFα inhibitors in inflammatory bowel diseases [27,28]. This evidence concerns the gene IL1B and inflammatory bowel disease.